| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
3 companies
Mpm Bioventures 2014, L.P. is a Former 10% Owner at HOWL, with reported holdings spanning 3 companies. Recent filings cover 3 purchases and 43 sales. Those positions are worth an estimated $32.3M at current prices.
Our model assigns Mpm Bioventures 2014, L.P. a middling insider score of 67/100, based on 33 past trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +8.0%.
Mpm Bioventures 2014, L.P.'s largest disclosed position is in TRDA as 10% Owner, worth about $27.7M. The recent filings there lean toward selling, a net 440,669 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Sell | 259,837 | $7.33 | $1,905,767.81 | -6.3% | - | - | |
| Sep 3, 2026 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Sell | 86,482 | $7.14 | $617,378.88 | -2.0% | - | - | |
| Aug 31, 2026 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Sell | 86,914 | $7.08 | $615,777.14 | -2.0% | - | - | |
| Aug 26, 2026 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Sell | 62,714 | $7.36 | $461,545.84 | -1.4% | - | - | |
| Dec 4, 2025 | HOWL Werewolf Therapeutics, Inc. | Former 10% Owner | Sell10b5-1 | 199,732 | $0.92 | $183,275.38 | -4.0% | -38.8% | - | |
| Dec 1, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell10b5-1 | 141,927 | $0.96 | $136,854.55 | -2.8% | -36.4% | - | |
| Nov 25, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell10b5-1 | 195,666 | $0.92 | $179,551.05 | -3.7% | -27.5% | - | |
| Nov 20, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell10b5-1 | 160,103 | $0.92 | $147,912.95 | -2.9% | -22.9% | - | |
| Nov 17, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell10b5-1 | 209,652 | $0.96 | $200,665.13 | -3.7% | -28.4% | - | |
| Nov 12, 2025 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Sell10b5-1 | 213,529 | $1.13 | $241,278.01 | -3.6% | -34.2% | - |